| MolName | (4E)-4-[(E)-3-[5-carboxy-3-oxo-2-(4-sulfophenyl)-1H-pyrazol-4-yl]prop-2-enylidene]-5-oxo-1-(4-sulfophenyl)pyrazole-3-carboxylic acid |
| MolecularFormula | C23H16N4O12S2 |
| Smiles | OC(C(/C(/C1=O)=C\C=C\C(C2=O)=C(C(O)=O)NN2c(cc2)ccc2S(O)(=O)=O)=NN1c(cc1)ccc1S(O)(=O)=O)=O |
| InChI | InChI=1S/C23H16N4O12S2/c28-20-16(18(22(30)31)24-26(20)12-4-8-14(9-5-12)40(34,35)36)2-1-3-17-19(23(32)33)25-27(21(17)29)13-6-10-15(11-7-13)41(37,38)39/h1-11,24H,(H,30,31)(H,32,33)(H,34,35,36)(H,37,38,39) |
| InChIK | SFWSBBFIPHWMPI-UHFFFAOYSA-N |
| TotalMolweight | 604.528 |
| Molweight | 604.528 |
| MonoisotopicMass | 604.020616 |
| CLogP | -3.88 |
| CLogS | 0.183 |
| H Acceptors | 16 |
| H Donors | 5 |
| TotalSurfaceArea | 388.74 |
| Relative PSA | 0.49336 |
| PolarSurfaceArea | 265.11 |
| Druglikeness | 5.0247 |
| Mutagenic | high |
| Tumorigenic | none |
| Reproductive Effective | low |
| Irritant | high |
| Nasty Functions | twice activated DB |
| Shape Index | 0.5122 |
| Fragments | 1 |
| Non HAtoms | 41 |
| NonCHAtoms | 18 |
| Electronegative Atoms | 18 |
| Rotatable Bond | 8 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 6 |
| Symmetricatoms | 6 |
| AcidicOxygens | 4 |
| StereoCon |
Click to Load Molecule:
1 - (4E)-4-[(E)-3-[5-carboxy-3-oxo-2-(4-sulfophenyl)-1H-pyrazol-4-yl]prop-2-enylidene]-5-oxo-1-(4-sulfophenyl)pyrazole-3-carboxylic acid | 2 - (4E)-4-[(E)-3-[5-carboxy-3-oxo-2-(4-sulfophenyl)-1H-pyrazol-4-yl]prop-2-enylidene]-5-oxo-1-(4-sulfophenyl)pyrazole-3-carboxylic acid